Forecast & Rating3 analysts currently cover Aprea Therapeutics, of which 3 give a positive rating. The average price target is $3.73, about 409.7% upside from the current price of $0.73. Coverage is limited, so the data is for reference only. Data as of Sep 8, 2026; this does not constitute investment advice.
Sep 8, 2026Price forecast
$3.73409.74%
Forecast & RatingStrong buy
3analysts
- Strong buy66.67%
- Buy33.33%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 21, 2026
Forecast met1.3%
Stock price$0.73
Avg. target$7.0
High target$11
Low target$5
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.